Michael Markus Bonelli (Michael Bonelli)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Immune Response

Top Venues

Annals of the rheumatic diseases

Arthritis & rheumatology (Hoboken, N.J.)

Journal of cellular and molecular medicine

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Markus H Hoffmann, Henriette Kirchner, Gerhard Krönke, Gabriela Riemekasten, Michael Markus Bonelli
Inflammatory tissue priming: novel insights and therapeutic opportunities for inflammatory rheumatic diseases. Annals of the rheumatic diseases (2024)
Maximilian Kugler, Mirjam Dellinger, Felix Kartnig, Lena Müller, Teresa Preglej, Leonhard X Heinz, Elisabeth Simader, Lisa Göschl, Stephan E Puchner, Sebastian Weiss, Lisa E Shaw, Matthias Farlik, Wolfgang Weninger, Giulio Superti-Furga, Josef S Smolen, Guenter Steiner, Daniel Aletaha, Hans P Kiener, Myles J Lewis, Costantino Pitzalis, Anela Tosevska, Thomas Karonitsch, Michael Markus Bonelli
Cytokine-directed cellular cross-talk imprints synovial pathotypes in rheumatoid arthritis. Annals of the rheumatic diseases (2023)
Michael Markus Bonelli, Andreas Kerschbaumer, Kastriot Kastrati, Kamran Ghoreschi, Massimo Gadina, Leonhard X Heinz, Josef S Smolen, Daniel Aletaha, John O'Shea, Arian Laurence
Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story. Annals of the rheumatic diseases (2023)
Lisa Sandner, Marlis Alteneder, Ramona Rica, Barbara Woller, Eleonora Sala, Tobias Frey, Anela Tosevska, Ci Zhu, Moritz Madern, Matarr Khan, Pol Hoffmann, Alexandra Schebesta, Ichiro Taniuchi, Michael Markus Bonelli, Klaus Georg Schmetterer, Matteo Iannacone, Mirela Kuka, Wilfried Ellmeier, Shinya Sakaguchi, Ruth Herbst, Nicole Boucheron
The guanine nucleotide exchange factor Rin-like controls Tfh cell differentiation via CD28 signaling. The Journal of experimental medicine 220 (11) (2023)
Thomas Karonitsch, Victoria Saferding, Markus Kieler, Karolina von Dalwigk, Anela Tosevska, Gerwin Heller, Mirjam Dellinger, Birgit Niederreiter, Felix Kartnig, Carl W Steiner, Philippe Georgel, Hans P Kiener, Josef S Smolen, Adelheid Korb-Pap, Michael Markus Bonelli, Daniel Aletaha, Stephan Blüml
Amino acids fuel fibroblast-like synoviocyte activation and arthritis by regulating chemokine expression and leukocyte migration. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Daniel Mrak, Elisabeth Simader, Daniela Sieghart, Peter Mandl, Helga Radner, Thomas Perkmann, Helmuth Haslacher, Margareta Mayer, Maximilian Koblischke, Philipp Hofer, Lisa Göschl, Felix Kartnig, Thomas Deimel, Andreas Kerschbaumer, Thomas Hummel, Barbara Kornek, Renate Thalhammer, Karin Stiasny, Stefan Winkler, Josef S Smolen, Judith H Aberle, Daniel Aletaha, Leonhard X Heinz, Michael Markus Bonelli
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study. Annals of the rheumatic diseases 81 (12) (2022)
Michael Markus Bonelli, Daniel Mrak, Selma Tobudic, Daniela Sieghart, Maximilian Koblischke, Peter Mandl, Barbara Kornek, Elisabeth Simader, Helga Radner, Thomas Perkmann, Helmuth Haslacher, Margareta Mayer, Philipp Hofer, Kurt Redlich, Emma Husar-Memmer, Ruth Fritsch-Stork, Renate Thalhammer, Karin Stiasny, Stefan Winkler, Josef S Smolen, Judith H Aberle, Markus Zeitlinger, Leonhard X Heinz, Daniel Aletaha
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial. Annals of the rheumatic diseases 81 (5) (2022)
Felix Kartnig, Daniel Mrak, Elisabeth Simader, Selma Tobudic, Helga Radner, Peter Mandl, Lisa Göschl, Nikolaus Hommer, Margareta Mayer, Philipp Hofer, Thomas Hummel, Thomas Deimel, Irina Geßl, Antonia Puchner, Andreas Kerschbaumer, Renate Thalhammer, Alessandra Handisurya, Renate Kain, Stefan Winkler, Josef S Smolen, Karin Stiasny, Thomas Perkmann, Helmuth Haslacher, Judith H Aberle, Daniel Aletaha, Leonhard X Heinz, Daniela Sieghart, Michael Markus Bonelli
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls. Annals of the rheumatic diseases (2022)
Daniel Mrak, Daniela Sieghart, Elisabeth Simader, Selma Tobudic, Helga Radner, Peter Mandl, Lisa Göschl, Maximilian Koblischke, Nikolaus Hommer, Angelika Wagner, Margareta Mayer, Lorenz Schubert, Lukas Hartl, Karin Kozbial, Philipp Hofer, Felix Kartnig, Thomas Hummel, Andreas Kerschbaumer, Thomas Deimel, Antonia Puchner, Venugopal Gudipati, Renate Thalhammer, Petra Munda, Keziban Uyanik-Ünal, Andreas Zuckermann, Gottfried Novacek, Thomas Reiberger, Erika Garner-Spitzer, Roman Reindl-Schwaighofer, Renate Kain, Stefan Winkler, Josef S Smolen, Karin Stiasny, Gottfried F Fischer, Thomas Perkmann, Helmuth Haslacher, Markus Zeitlinger, Ursula Wiedermann, Judith H Aberle, Daniel Aletaha, Leonhard X Heinz, Michael Markus Bonelli
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial. Nature communications 13 (1) (2022)
Michael Markus Bonelli, Helga Radner, Andreas Kerschbaumer, Daniel Mrak, Martina Durechova, Jutta Stieger, Rusmir Husic, Peter Mandl, Josef S Smolen, Christian Dejaco, Daniel Aletaha
Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trial. Annals of the rheumatic diseases 81 (6) (2022)
Daniel Mrak, Selma Tobudic, Maximilian Koblischke, Marianne Graninger, Helga Radner, Daniela Sieghart, Philipp Hofer, Thomas Perkmann, Helmuth Haslacher, Renate Thalhammer, Stefan Winkler, Stephan Blüml, Karin Stiasny, Judith H Aberle, Josef S Smolen, Leonhard X Heinz, Daniel Aletaha, Michael Markus Bonelli
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity. Annals of the rheumatic diseases 80 (10) (2021)
Michael Markus Bonelli, Daniel Mrak, Thomas Perkmann, Helmuth Haslacher, Daniel Aletaha
SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response. Annals of the rheumatic diseases 80 (10) (2021)
Gavin R Meehan, Ranjeny Thomas, Shaima Al Khabouri, Pascale Wehr, Catharien Mu Hilkens, David C Wraith, Daniela Sieghart, Michael Markus Bonelli, György Nagy, Paul Garside, David F Tough, Huw D Lewis, James M Brewer
Preclinical models of arthritis for studying immunotherapy and immune tolerance. Annals of the rheumatic diseases 80 (10) (2021)
Michael Markus Bonelli, Daniel Aletaha
Response to: 'Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'' by Westhoff et al. Annals of the rheumatic diseases 80 (10) (2021)
Michael Markus Bonelli, Daniel Aletaha
Response to: Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli et al. Annals of the rheumatic diseases 80 (10) (2021)
Michael Markus Bonelli, Antonia Puchner, Lisa Göschl, Silvia Hayer, Birgit Niederreiter, Guenter Steiner, Katharina Tillmann, Roberto Plasenzotti, Bruno Podesser, Philippe Georgel, Josef Smolen, Clemens Scheinecker, Stephan Blüml
CCR6 controls autoimmune but not innate immunity-driven experimental arthritis. Journal of cellular and molecular medicine 22 (11) (2018)